Brief: Synact Pharma Q4 Pretax Loss Narrows To SEK 9.8 Million
Feb 12 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q4 PRETAX LOSS SEK 9.8 MILLION VERSUS LOSS SEK 11.2
MILLION YEAR
AGO
Source text for Eikon: ID:nWkr3d8FPR
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026